急性肾损伤:预防、检测与管理——成人接受碘对比剂时NICE更新指南概要
英国国家卫生与临床优化研究所(NICE)更新了急性肾损伤(AKI)指南(NG148),针对成人接受静脉碘对比剂时AKI预防提出新推荐。指南指出对比剂与AKI的关联主要基于观察性研究且存在异质性,不推荐常规使用静脉扩容或口服乙酰半胱氨酸预防,建议鼓励高危成人口服水化,仅对住院且风险特别高的患者考虑静脉扩容。
要点
- 非急诊情况下,使用静脉碘对比剂前应获取3个月内的肾小球滤过率(GFR)测量值。
- 急诊情况下,使用静脉碘对比剂前应评估AKI风险,但不应因此延迟急诊影像检查。
- 对AKI风险增加的成人应鼓励口服水化;仅对住院且风险特别高的患者考虑静脉扩容。
诊断标准与关键数值
- 非急诊情况下,使用静脉碘对比剂前应获取3个月内的肾小球滤过率(GFR)测量值。
- 急诊情况下,使用静脉碘对比剂前应评估成人AKI风险,但不应延迟急诊影像检查。
- 对AKI风险增加的成人应鼓励口服水化。
- 仅对住院且风险特别高的患者考虑静脉扩容。
临床应用与阅片要点
- 非急诊使用静脉碘对比剂前应获取3个月内的GFR测量值。
- 急诊使用静脉碘对比剂前应评估AKI风险,但不应因此延迟急诊影像检查。
- 对AKI风险增加的成人应鼓励口服水化。
- 仅对住院且风险特别高的患者考虑静脉扩容。
- 对比剂相关AKI的关联主要基于观察性研究,存在患者人群、定义和实验室检查时机上的固有异质性。
局限性
- 对比剂给药与AKI的关联主要基于观察性研究,患者人群、所应用的定义及实验室检查时机存在固有异质性。
- 静脉扩容和/或口服乙酰半胱氨酸的肾脏保护干预虽广泛使用,但缺乏高质量获益证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The National Institute for Health and Care Excellence (NICE) has recently updated the guideline for Acute kidney injury: prevention, detection and management (NG148), providing new recommendations on preventing acute kidney injury (AKI) in adults receiving intravenous iodine-based contrast media. The association between intravenous iodinated contrast media and AKI is controversial, particularly with widespread use of iso-osmolar agents. Associations between contrast media administration and AKI are largely based on observational studies, with inherent heterogeneity in patient populations, definitions applied, and timing of laboratory investigations. In an attempt to mitigate risk, kidney protection has typically been employed using intravenous volume expansion and/or oral acetylcysteine. Such interventions are in widespread use, despite lacking high-quality evidence of benefit. In the non-emergency setting, glomerular filtration rate (GFR) measurements should be obtained within the preceding 3 months before offering intravenous iodine-based contrast media. In the acute setting, adults should also have their risk of AKI assessed before offering intravenous iodine-based contrast media; however, this should not delay emergency imaging. Based on the evidence available from randomised controlled trials, the NICE committee recommends that oral hydration should be encouraged in adults at increased risk of AKI and that volume expansion with intravenous V fluids should only be considered for inpatients at particularly high risk.
引用
- Barrett T, Khwaja A, Carmona C, et al. Acute kidney injury: prevention, detection, and management. Summary of updated NICE guidance for adults receiving iodine-based contrast media. Clin Radiol. 2020. PMID: 33390251. doi:10.1016/j.crad.2020.08.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。